%0 Journal Article %T Medicinal Synthetic Aluminum-Magnesium Silicate <br/>{Al<sub>4</sub>(SiO<sub>4</sub>)<sub>3</sub> + 3Mg<sub>2</sub>SiO<sub>4</sub> ¡ú 2Al<sub>2</sub>Mg<sub>3</sub>(SiO<sub>4</sub>)<sub>3</sub>} ¡ªA Highly Active Anti-Retroviral Medicine %A Maduike C. O. Ezeibe %A Ijeoma J. Ogbonna %J World Journal of AIDS %P 42-46 %@ 2160-8822 %D 2016 %I Scientific Research Publishing %R 10.4236/wja.2016.62006 %X Medicinal synthetic Aluminum-magnesium silicate (MSAMS), which has inhibited Human immune deficiency virus (HIV), in vitro, was used for trial-treatment of HIV/AIDS patients. Their plasma were tested for viral loads (VL): before and repeatedly during the treatment. The regimen was: MSAMS (50 mg/kg), MSAMS-stabilized Ampicillin trihydrate (7.5 mg/kg) and immunace extra protection?. After 4 weeks, it was reduced to 50 mg/kg (MSAMS) and the immune stimulant. When VL decreased bellow 50/ml, the treatment continued, 4 weeks before stopping. Mean-VL of four patients increased (P = 0.006) from 498.50 ¡À 33.37 to 1,072.50 ¡À 184.55, after 3.75¡À2.06 weeks and decreased (P = 0.040) to 407.33 ¡À 297.27 (18.29%) when the treatment-duration increased to 6.67 ¡À 2.31 weeks. Prolonging the duration to 12.00 ¡À 2.83 weeks led to 98.68% decrease of mean-VL of four other patients, from 24,250.00 ¡À 15,939.34 to 321.00 ¡À 229.38(P = 0.045). Two HIV positive persons treated for 4 weeks after their VL reduced bellow 50/ml have remained healthy, 10 and 16 months respectively, without routine antiretroviral medication. %K MSAMS-Nanoparticles %K Unmasking ¡°Hidden Infections¡± %K Moping-Out HIV %K Access to All Organs/Tissues %U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=65804